RAC 1.11% $1.83 race oncology ltd

General Comments / Chat, page-4578

  1. 2,621 Posts.
    lightbulb Created with Sketch. 2758
    Just checking Amgen and their strategy and seems like they are investigating combo therapies to get the most out of Krypolis (carfilzomib). Plus investigations on ALL, MRD and Multiple Myeloma. Guess (carfilzomib) cardio protective combo with Zantrene is not a mere fluke along with other indications.

    Oldest trick in the book, Find a problem that already exists and present the solution!

    Source: Amgen Announces New Data Being Presented At ASH 2021| Amgen

    https://hotcopper.com.au/data/attachments/3905/3905939-eb322a51b08a447536f5368fbe3a30d0.jpg
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.8M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.